🇺🇸 FDA
Pipeline program

Tirzepatide

R+D: A097457, REC: 25/WA/0268

Unknown small_molecule active

Quick answer

Tirzepatide for Hypertension is a Unknown program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Hypertension
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials